Clinical Trials Browser

Neurotoxicity Syndromes × Folfox protocol × Gastrointestinal × Clear all

NCT05494320 2022-08-09

the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

Gastrointestinal

Gastrointestinal Neoplasms, Neurotoxicity Syndromes

NCT00884767 2009-07-08

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

Phase 2 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes